We have been funding ground-breaking new research to impact the lives of those affected by a prostate cancer diagnosis.
Dr Olugbenga Samuel Oyeniyi profiled in Nature about his PCR-funded project focused on delivering workshops to black men across the UK.
This project delves into the barriers faced by black men and the early diagnosis of prostate cancer and encourages men to seek help or advice early to reduce the number of late diagnoses.
The findings could lead to a test to identify those at greatest risk of developing the disease, enhancing survival rates.
Using this in combination with the PSA test, which scans for prostate-specific antigens in your blood, has been shown to dramatically improve detection by 94 percent in cases.
This test will help reduce unnecessary prostate biopsies and false negatives in men who have the disease. It will also help us identify markers of prostate cancer that may be specific to an ethnic group.
These signals encourage prostate cancer cells to grow. Our scientists are investigating how these cell signals affect prostate cancer growth and it’s spread by comparing the signals from the cells of obese men to those of lighter men.
This research will allow us to identify existing drugs that can be repurposed to treat prostate cancer cells.
Everyone facing a cancer diagnosis should have access to the same quality of treatment and care but currently this is not the case. A postcode lottery of cancer testing and diagnostic tools means that where you live can make a huge difference to your outcomes.
‘Postcode lottery’ in prostate cancer care costs thousands of lives a year as men in the north east of England are SIX TIMES more likely to receive a diagnosis after it has spread, charity warns
The charity said it was a ‘national tragedy’ that survival prospects for the most common cancer among men could come down to where they live. It estimates around 3,000 lives a year could be saved by reducing the disparities in late diagnosis – and called on more men to come forward to be tested.
DAILY MAIL COMMENT: A rallying cry to take on the silent killer
We reveal today that there is effectively a postcode lottery for men’s survival prospects, with many hospitals in the South far outperforming those in the North and the Midlands – a shameful imbalance in our health system which is responsible for an estimated 3,000 deaths a year.
Which is why our End The Needless Prostate Deaths campaign is supporting the call by Soho House founder Nick Jones in Saturday’s Mail for the NHS to offer all men over the age of 50 a free scan which can spot the cancer early.
‘I had to travel 100 miles for prostate cancer treatment EVERY day’: Patient is forced to make huge daily journey to receive radiotherapy
Nick Fletcher was forced to travel 100 miles every day for a month to receive life-saving treatment.
The 58-year-old from Malton, North Yorkshire, travelled 50 miles to a hospital in Leeds each morning for radiotherapy.
He was diagnosed with prostate cancer at the Magnolia Centre in York Hospital. Yet Mr Fletcher was left with little choice but to take on the ‘tiring’ two-and-a-half-hour roundtrip journey to and from St James’s University Hospital in Leeds.
Men with prostate cancer are being diagnosed late and suffering avoidable death because ‘GPs don’t take them seriously’
Men with prostate cancer are being diagnosed late and suffering avoidable deaths because they have to fight to be taken seriously by doctors, damning figures suggest.
They typically wait longer than other patients before seeking help with symptoms – and then have to return to their GP multiple times before getting a diagnosis.
Too many are not told in a sensitive way that they have the disease or struggle to contact healthcare workers for support during treatment, according to the NHS National Cancer Patient Experience Survey.
Men should be offered ‘one stop shop’ tests for prostate cancer similar to those widely available to breast cancer to help save lives, say experts
Men should be offered a ‘one-stop shop’ for prostate cancer tests similar to those widely available for breast cancer, experts say.
A pilot scheme in London found the time to make a diagnosis could be cut in half by fast-tracking men suspected of having the disease.
They were offered an MRI scan, with the results the same day – and in many cases a biopsy the same day if needed.
In December 2022, we launched a campaign #GiveMenMoreTime to ensure men with advanced prostate cancer are not left behind when it comes to approving new drugs on the NHS in England and Wales.
Up to 12,000 men are dying from prostate cancer in England each year because they are denied groundbreaking drugs on the NHS, charities warn
Up to 12,000 men are dying from prostate cancer in England each year because they are denied groundbreaking drugs on the NHS, charities warn.
Three charities have united with actor Stephen Fry, who survived the disease, to call for precision treatments Olaparib and Pluvicto to be made available.
Olaparib is the world’s first genetically targeted drug to be proven safe and effective for advanced prostate cancer for men with the BRCA 1/2 mutation.
1 in 4 Black men will get prostate cancer, like I did. It’s time for government to make life-extending drug available.
I WAS diagnosed with prostate cancer back in 2021, and I know what it feels like to have your time threatened by a serious illness.
In 2020, I had a slightly raised PSA result and was told to keep an eye on it and come back again in 12 months.
A year later, I was getting a bit sore, having ridden a static bike in the gym for around six months, and I started having more trips to the toilet at night, as well as having more urgency when I needed to go.
In 2023, we launched our patient platform, the infopool.
Elton John lookalike shares real life health battle parallels with the music icon
The Elton John lookalike is supporting Prostate Cancer Research’s new National Lottery funded website resource called the infopool, which includes information about testing for the disease, clinical trials and patient videos.
The infopool was co-designed with patients and clinicians, and aims to help support those at risk of the disease and those diagnosed with prostate cancer, to help understand the lived experience of people like them.
Elton John lookalike to star in prostate cancer charity videos
Mr Bills is working with the charity Prostate Cancer Research in his role as Sir Elton in a series of online videos to highlight a new National Lottery-funded information website.
The website, called The Infopool, is run by the charity and contains details about prostate cancer, testing, treatment and clinical trials.
Tackling the health inequities faced by Black men in prostate cancer
Two universities in East of England involved in pioneering prostate cancer research
Prostate Cancer affects all men, but those who are black are twice as likely to develop and die from prostate cancer.
Now scientists are leading the way when it comes to understanding why that is with new research projects at the University of East Anglia and the University of Essex.
Professor Bart Cornelissen and Dr Tiffany Chan appeared on BBC South Today to discuss their PCR-funded project combining radiotherapy with other drugs to improve patient outcomes.
We teamed up with cancer care provider GenesisCare and Linford Christie OBE, Olympian and Prostate Cancer Campaigner.
A Wiltshire man who survived prostate cancer is warning other black men they are twice as likely as white men to develop the disease, and says his own awareness saved his life.
ONE in four black men will be diagnosed with prostate cancer during their lifetime as under a quarter know they are at a higher risk, a survey has revealed.
LINFORD CHRISTIE has opened up on his aim to encourage people to speak about cancer while urging fans to get health checks to catch the disease as early as possible.
Prostate cancer survivor & music therapist Alphonso Archer and PCR Head of Research Dr Naomi Elster spoke to 5 News as part of our work with GenesisCare and Linford Christie OBE to raise awareness of the increased risk of prostate cancer in black men.
Together with cancer care provider GenesisCare and Dominic Littlewood, TV presenter and prostate cancer survivor, we aimed to empower men at every stage of their prostate cancer journey.
A study of 2,000 adults found 78 per cent of men are also unaware of the physical symptoms which could indicate an issue. In fact, women are 27 per cent more likely to know the signs to look out for, and a third (34 per cent) of the men who have received a prostate cancer diagnosis admitted that it was their partner who raised the alarm.
Nearly half of men have no idea where their prostate is, and are unaware of the physical symptoms which could indicate an issue, according to research. A study of 2,000 adults revealed that women – who do not have a prostate – are 27 percent more likely to know the signs to look out for in a man.
Nearly half of men have no idea where the prostate is, according to research. A study of 2,000 adults found 78 per cent of men are also unaware of the physical symptoms which could indicate an issue.
A huge thank you to Allan Lamb for opening up about his experiences with prostate cancer & highlighting our work in The Telegraph.
Former England batsman Lamb is being treated for prostate cancer and tells men not to die ‘from embarrassment’. Since revealing he has the disease, he has been inundated with support and is urging others to get checked.
Earlier this year, Prostate Cancer Research (PCR), in partnership with Tackle Prostate Cancer and pharmaceutical company Ipsen, launched a nationwide survey to better understand the experiences faced by people living with prostate cancer, particularly in relation to the challenges patients face with treatment side effects.
A Calne cancer survivor is hoping his story will help others, and has volunteered to go public in a charity campaign.
Michael Woolley was diagnosed with prostate cancer in August 2018, after a chat with his work friend encouraged him to get checked out.
When Mark Dalloway, 57, learned he carried the BRCA2 gene mutation, he knew he had to take action.
In April 2020, we invited researchers to submit proposals and recently announced the scientist who were awarded funding.
A group of London scientists are receiving funding to fill the gaps in the research landscape of prostate cancer.
Dr Claire fletcher is one of those behind the research and spoke to James about how the research and how she’ll be using the funding.
PCR CEO, Oliver Kemp, appeared on Sky News to discuss a new blood test to detect 50 types of cancer being piloted by the NHS and what this will mean for prostate cancer patients
The COVID-19 pandemic has had huge impacts on everyone in society. Earlier this year, we launched our survey, 'Living with prostate cancer: how has COVID-19 affected you?'
Findings show the proportion of those told they have prostate cancer who don’t get an initial face-to-face consultation has risen eight-fold.
Newly diagnosed cancer patients are being forced to speak to their specialist over the phone or via video call rather than in person, experts have warned.
If you are a journalist and would like to get in touch about a potential story, please email [email protected].
